|
🦁
|
Severe disease reactivation in four patients with relapsing–remitting multiple sclerosis after fingolimod cessation
7 auth.
B. Berger,
A. Baumgartner,
S. Rauer,
I. Mader,
Niklas Luetzen,
Ulrich Farenkopf,
...
O. Stich
|
6 |
2015 |
6
🦁
|
|
🐜
|
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients
22 auth.
Christopher Nelke,
Frauke Stascheit,
C. Eckert,
M. Pawlitzki,
Christina B. Schroeter,
Niklas Huntemann,
P. Mergenthaler,
Ercan Arat,
Menekşe Öztürk,
D. Foell,
...
S. Schreiber,
S. Vielhaber,
A. Gassa,
H. Stetefeld,
M. Schroeter,
B. Berger,
A. Totzeck,
T. Hagenacker,
S. Meuth,
A. Meisel,
H. Wiendl,
T. Ruck
|
6 |
2022 |
6
🐜
|
|
🐜
|
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression
14 auth.
Maike Michel,
B. Fiebich,
H. Kuzior,
Sophie Meixensberger,
B. Berger,
S. Maier,
K. Nickel,
K. Runge,
D. Denzel,
Benjamin Pankratz,
...
M. Schiele,
K. Domschke,
L. V. van Elst,
D. Endres
|
5 |
2021 |
5
🐜
|
|
🦁
|
Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unit.
B. Berger,
C. Gumbinger,
T. Steiner,
M. Sykora
|
5 |
2014 |
5
🦁
|
|
🐜
|
The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort
7 auth.
T. Hottenrott,
R. Dersch,
B. Berger,
S. Rauer,
M. Eckenweiler,
D. Huzly,
...
O. Stich
|
5 |
2015 |
5
🐜
|
|
🐬
|
“Non-classical” paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to “classical” syndromes — More frequent than expected
B. Berger,
P. Bischler,
R. Dersch,
T. Hottenrott,
S. Rauer,
O. Stich
|
5 |
2015 |
5
🐬
|
|
🐜
|
Eculizumab versus rituximab in generalised myasthenia gravis
23 auth.
Christopher Nelke,
Christina B. Schroeter,
Frauke Stascheit,
M. Pawlitzki,
Liesa Regner-Nelke,
Niklas Huntemann,
Ercan Arat,
Menekşe Öztürk,
N. Melzer,
P. Mergenthaler,
...
A. Gassa,
H. Stetefeld,
M. Schroeter,
B. Berger,
A. Totzeck,
T. Hagenacker,
S. Schreiber,
S. Vielhaber,
H. Hartung,
A. Meisel,
H. Wiendl,
S. Meuth,
T. Ruck
|
5 |
2022 |
5
🐜
|
|
🐬
|
The MRZ reaction in primary progressive multiple sclerosis
T. Hottenrott,
R. Dersch,
B. Berger,
S. Rauer,
D. Huzly,
O. Stich
|
5 |
2017 |
5
🐬
|
